Musculoskeletal
Adolescent Idiopathic Scoliosis
11
Pipeline Programs↗
6
Active Trials↗
2
Companies Involved↗
Adolescent Idiopathic Scoliosis is an emerging landscape with 11 programs across 2 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Amring. 7 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 23
Phase 3
No programs
Analysis
Trial Status
11
clinical trials
Completed3 · 27%
Recruiting3 · 27%
Not yet recruiting2 · 18%
Suspended1 · 9%
Terminated1 · 9%
Active, not recruiting1 · 9%
Clinical Trials
Trial Activity
11 trials
Opioid-Free Anesthesia Versus Opioid Based Anesthesia For Adolescent Idiopathic Scoliosis
Recruiting·—·Phase 4·NCT07389096·30 enrolled
Postoperative Steroid Use in Adolescent Idiopathic Scoliosis and Neuromuscular Scoliosis Patients
Not yet recruiting·—·Phase 4·NCT06023043·100 enrolled
Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery
Terminated·—·Phase 2·NCT06096181·13 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)